Purpose
To develop a quality-compliant laboratory assay that strengthens regional capacity to assess immune responses to respiratory infections and supports the generation of reliable evidence to inform vaccine research and public health decisions.
Grantee
Division
Global Health
Date
JULY 2026
Region served
AFRICA
Committed amount
$1,704,024
Grant topic
Discovery and Translational Sciences,
Pneumonia & Pandemic Preparedness,
Vaccine Development
Duration (months)
24
Grantee location
Rondebosch, Western Cape, South Africa
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.